Reply to ‘The method matters: free water imaging in Parkinson’s disease is not a binary verdict’ Authors: Yun Hwa Roh, Jinyoung Youn, Sang-Young Kim, Hwan Heo, Soohwa Song, Beomseok Sohn Published: 2026 ABSTRACT AbstractWe reply to the Matters Arising on our study comparing neuromelanin and free water imaging for early Parkinson’s disease diagnosis. The authors raised considerations regarding image registration, age imbalance, repetition time, and conceptual framing. We clarify that our registration pipeline is validated for subcortical structures, that age does not account for neuromelanin’s superior performance, and that our acquisition parameters meet recommended standards. Our findings reflect comparative performance, not a verdict.Subject terms: Medical research, Neurology, Neuroscience We thank the authors for their thoughtful engagement with our recent work on the comparative diagnostic performance of neuromelanin (NM) and free water (FW) imaging in early Parkinson’s disease (PD)1 and for raising important methodological considerations regarding FW imaging. We agree that the technical implementation of FW imaging is a critical determinant of its diagnostic sensitivity, and we welcome the opportunity to clarify our methodology and address each of the points raised. Registration template choice We acknowledge that fractional anisotropy (FA)-based templates can provide improved alignment in white matter tract analyzes where FA contrast is high. However, for subcortical structures such as the substantia nigra (SN), FA contrast is inherently low, and the optimal registration approach for such regions remains debated. A systematic comparison of nonlinear deformation algorithms for subcortical alignment demonstrated that ANTs Symmetric Normalization (SyN) — the registration framework employed in our pipeline — achieved the highest Dice coefficient and reached accuracy comparable to inter-rater manual segmentation2. We wish to clarify that our diffusion tensor imaging (DTI) data were not directly registered to an MNI template. We employed a two-step ANTs-based registration in which DTI volumes were first aligned to each subject’s native T1-weighted image (resampled to 1.5-mm isotropic resolution), and the concatenated transformations were then inverted to bring the SN mask back into native DTI space. The SN mask was derived from a high-resolution 7T-based ATAG atlas. Comparable T1-based registration strategies have been previously employed in FW imaging of the SN and successfully detected FW elevations in idiopathic REM sleep behavior disorder3 and PD4, supporting the validity of this approach. Furthermore, the identical pipeline was applied to both FW and NM analyzes. Although two modalities rely on different biophysical principles and have distinct technical sensitivities, the consistent performance of the pipeline in detecting NM differences suggests that registration error may not fully account for the absence of FW group differences. We additionally note that in our external validation cohort, FW values were elevated in the associative subregion of patients with early PD despite the use of the same registration approach, indicating that the pipeline can detect subregional FW differences when present. Age imbalance between groups The age difference between our early PD and control groups (median 67 vs. 70 years) was statistically significant but clinically modest, with both groups falling within a narrow range near the plateau of the NM signal–age trajectory5. We agree with the authors’ observation that age and PD influence FW in the same direction, whereas their effects on the NM signal in this age range differ. To address potential confounding, we incorporated age and sex as covariates in our logistic regression-based ROC analyzes and reported adjusted AUCs accordingly; NM measures continued to outperform FW under these adjusted analyzes. Our multivariable regression analyzes further demonstrated that NM volume was not significantly age-associated in any subregion, whereas FW values were age-dependent in multiple subregions of both the early PD cohort and the combined analysis. Also, in our independent external validation cohort, age did not differ significantly between early PD and control groups (median 67 vs. 66 years), yet NM measures continued to demonstrate higher discriminative performance than FW. Repetition time (TR) length We respectfully note that the primary cohort in our study was acquired with a TR of 9225 ms, well above the >6000 ms threshold cited by the authors as recommended for FW imaging6. Despite the use of this longer TR, FW values did not differ significantly between early PD and control groups in the primary cohort. The external validation cohort employed a shorter TR (3100 ms) and a smaller voxel size (1 × 1 × 2 mm³), reflecting routine clinical acquisition parameters. Although these parameters may reduce sensitivity to subtle FW alterations, the diagnostic pattern observed in the external cohort was consistent with that of the primary cohort. We therefore consider the convergence of findings across two cohorts with different acquisition protocols to be a strength of our study. Nevertheless, we agree that future studies systematically optimizing diffusion acquisition parameters—including longer TR, multi-shell sampling, and adjusted voxel size—will be valuable for further characterizing FW sensitivity in early PD. Conceptual framing of FW imaging We agree with the authors that FW in the SN has not been established as a standalone diagnostic biomarker for PD, and our study does not position it as such. Our framing is explicitly comparative: we sought to provide a head-to-head evaluation of NM and FW imaging under harmonized acquisition and processing conditions within a rigorously defined early PD cohort. The conclusion that NM imaging demonstrated superior diagnostic performance in this specific context is not intended to dismiss the broader utility of FW imaging. In our Discussion, we acknowledged that our findings apply to the specific context of differentiating early PD from controls and emphasized the importance of future research evaluating NM and FW imaging in more clinically heterogeneous populations, including atypical Parkinsonism7,8 to determine their translational value in real-world diagnostic practice. We appreciate the authors for highlighting these critical technical considerations. Continued methodological refinement and validation across diverse clinical populations will be essential in defining the optimal roles of NM and FW imaging within the evolving diagnostic framework for PD. Author contributions Y.H.R.: drafting and editing of manuscript. J.Y.: drafting and editing of manuscript. S.K.: drafting and editing of manuscript. H.H.: drafting and editing of manuscript. S.S.: drafting and editing of manuscript. B.S.: drafting and editing of manuscript Data availability No datasets were generated or analysed during the current study. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.